Inter-assay variability in anti-JC virus serology in the era of natalizumab biosimilars: implications for PML risk stratification.
Saved in:
| Title: | Inter-assay variability in anti-JC virus serology in the era of natalizumab biosimilars: implications for PML risk stratification. |
|---|---|
| Authors: | Caminero AB; Department of Neurology, Complejo Asistencial de Ávila, Ávila, Spain., Oreja-Guevara C; Department of Neurology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.; Department of Medicine, Faculty of Medicine, Complutense University of Madrid (UCM), Madrid, Spain. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jul 29; Vol. 17, pp. 1818341. Date of Electronic Publication: 2026 Jul 29 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1818341 |
